Search In this Thesis
   Search In this Thesis  
العنوان
Updates in uses of chelation therapy /
المؤلف
Hassan, Mohammad Zayed Mohammad.
الموضوع
Clinical Toxicology. Penicillamine.
تاريخ النشر
2008.
عدد الصفحات
240 p. :
الفهرس
Only 14 pages are availabe for public view

from 270

from 270

Abstract

The word chelate refers to the ability to form tightly bound, non dissociable complexes with metal ions such as a claw would grasp an object. The metal chelate complexes are water-soluble and readily excreted in the urine. Heavy metal poisoning is a medical condition usually identified among those occupationally exposed, and which can have significant effects on nearly every organ system. The choice of chelating agent depends on which metal is involved. Common chelating agents include: DMSA, DMPS, CaNa2-EDTA , D-penicillamine, Deferoxamine, Defarasirox and BAL. Arthritis, arteriosclerosis, brain and renal diseases are all conditions that have been reported to show benefits from IV EDTA chelation. Some authors hypothesize that autism is an expression of mercury poisoning. Alzheimer’s disease may be completely reversible with zinc and copper chelation. Chelation therapy often given in combination with vitamins and minerals, has been touted as a safe alternative treatment for atherosclerotic vascular disease.
Key words
Heavy metals, Basophilic stippling, Arsenic, Chelation therapy, Mercury, Iron, Lead, Autism spectrum disorders, Thimerosal, Arsine, Deferoxamine challenge test , D-penicillamine Amalgam fillings, Acrodynia, British Anti-Lewisite, Kayser-Fleischer rings, Wilson’s disease, Penicillamine challenge, Neurodegeneration with brain iron accumulation, Alzheimer’s disease, Coronary artery disease, Deferoxamine , Dimercaprol, Edetate calcium disodium, Succimer.